Clinical study of NM441 on urinary tract infections

Keizo Suzuki, Masaki Horiba, Kiyohito Ishikawa, Yorio Naide, Kiyotaka Hoshinaga, Masanori Yanaoka, Shinobu Kato, Shinichi Ando, Norihiko Okishio, Haruyoshi Asano

研究成果: Article査読

1 被引用数 (Scopus)

抄録

NM441, a new oral quinolone antibiotic, was administered to 74 patients with urinary tract infections at a daily dose of 100~600mg for 3~47 days. The patients evaluable according to the criteria of the Japanese UTI Committee were 60 cases, and the clinical efficacy rates were 100% (11/11) in acute uncomplicated cystitis and 63.3% (31/49) in complicated urinary tract infections. Side effects were observed in a total of 5 cases; headache and nausea in 1 and digestive symptoms in 4. Abnormal laboratory findings were observed in a total of 3 cases; an elevation of GPT in 1, elevations of BUN and serum creatinine in 1 and an elevation of serum creatinine in 1.

本文言語English
ページ(範囲)678-683
ページ数6
ジャーナルJapanese Journal of Chemotherapy
44
SUPPL. 1
出版ステータスPublished - 1996
外部発表はい

All Science Journal Classification (ASJC) codes

  • 薬理学
  • 薬理学(医学)

フィンガープリント

「Clinical study of NM441 on urinary tract infections」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル